Directory of global suppliers across science, technology, industrial, medical and dental uses

www.utilisegold.com

Hello, you either have JavaScript turned off or an old version of Adobe's Flash Player. Get the latest Flash player.

Gold

Gold nanoclusters developed 'to boost medical research' > Gold News > Utilise Gold. Scientific, industrial and medical applications, products ,suppliers from the World Gold Council

 
 
 

Gold nanoclusters developed 'to boost medical research'

The news feeds on this site are independently provided by Adfero Limited © and do not represent the views or opinions of the World Gold Council.

Monday, 20th April 2009 (5354 views)

Scientists have developed gold nanoclusters that may be able to aid in both biological and medical research.

A team at the Institute of Bioengineering and Nanotechnology (IBN), which is part of Singapore's Agency for Science, Technology and Research, has created the clusters for the purpose of sub-cellular imaging.

They are designed to be used in the body to monitor DNA replication, as well as help investigate the effectiveness of drug and gene therapies.

The researcher's findings have been published in the Journal of the American Chemical Society and the gold nanoclusters could replace existing quantum dot technology, which is not suitable for use in the human body due to the presence of toxic metals.

Jackie Ying, of IBN, remarked: "There is a significant potential for our technology to impact biological and medical research, where our gold nanoclusters can significantly enhance the details available for precision bioimaging in medical diagnosis and treatment."

Nanoscientists at the University of Leicester were recently awarded a grant to help in a study aimed at early diagnosis and treatment of prostate cancer.

 

« Back to Gold News stories

 

Gold News Archive:

 
 
News provided by Adfero Ltd

Search

Search Utilise Gold.

  • Gold Spot Price
  • Bid: $1170.20
  • Ask: $1171.00
  • Last Update: 12:31 BST
  • 30 Jul 2010
© 2010 World Gold Council - all rights reserved. Produced and managed by CFP Group.